Stock screener

INVA

Conviction 47HealthcareScan · Mon, Jul 20, 2026
INVA$21.27-2.03%
ResistanceSupportVol 14Congress buyCongress sell
63 bars
Vol MA14 980.37K
Apr 20May 6May 26Jun 11Jul 1Jul 20
Innoviva, Inc.PHARMACEUTICAL PREPARATIONSwww.inva.com
Price21.27
Change-2.03%
Gap-0.37%
Rel volume2.63×
Avg volume1.02M
Avg $ vol22.92M
SMA 2022.44
SMA 5022.37
SMA 20021.35
Price vs 50-4.94%
Price vs 200-0.35%
MA stackmixed
50/200 cross
Supertrenddown · 23.22
RSI (14)38
MACD hist-0.11
MACD cross
Stoch %K / %D3 / 13
ADX (14)14
+DI / −DI18 / 28
RSI divergence
MACD divergence
ATR %+2.82%
ADR %2.67%
52w high24.24
52w low16.67
From 52w high-12.25%
Above 52w low+27.59%
New 52w highNo
SqueezeOff
Bollinger width11.97%
%B0.06
Donchian pos1.86%
Donchian high24.17
Donchian low21.22
AVWAP (52w high)22.60
vs AVWAP high-5.87%
AVWAP (52w low)21.55
vs AVWAP low-1.28%
OBV trendFlat
Chaikin MF (20)-0.18
Today vs 20d2.63×
Avg vol (14d)980.37K
Avg vol (20d)1.02M
Avg $ vol (20d)22.92M
Market cap1.57B
RS 3m (vs SPY)-13.94%
RS 6m (vs SPY)+2.31%
RS line new highNo
Trend template4/8
Technical rank43.4
1 week-4.23%
1 month-6.05%
3 months-12.25%
6 months+7.64%
1 year+6.99%
YTD+7.05%
P/E
P/B1.17
P/S3.82
P/FCF8.02
EPS3.30
Div yield
ROE
ROA
Debt/Eq0.20
Current21.13
EV/EBITDA6.98
Gross margin74.80%
Net margin
Rev growth14.67%
EPS growth
Price target35.33
Target upside66.10%
Analyst ratingBuy
Institutional113.96%
Ent. value1.24B
Revenue97.99M
Net income4.43M
Gross profit75.83M
Free cash flow195.8M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out73.81M
Employees159
ListedTue, Oct 5, 2004
Free float69.7M
Float %94.1%
Short interest6.65M
Days to cover6.8d
Short volume49.6%
Squeeze score65 / 100
Next earnings
EPS forecast
Last EPS vs est$0.44 vs $0.43
Last surprise+2.3% beat
Setup gradeC
Conviction47 / 100
Pattern quality
Tech rank43.4 / 100
Group rank23 / 100
Status laneNo active setup
Setup direction
Pattern family
Resistance23.77
Support21.40
Days since event
Candle confirm
News sentiment

Financials as of Thu, Mar 31, 2016 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 32 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

  1. Setting up
    Jun 9
    1 scan
  2. Breaking out now
    Jun 10 – Jun 12
    3 scans
  3. Setting up
    Jun 16 – Jun 22
    2 scans

Congress activity

Disclosed STOCK Act trades in INVA · 2 recent

All disclosures →
MemberSideAmount
George Whitesides
George Whitesides
house · D · CA · traded 2025-03-25
Sell$250K–$500K
George Whitesides
George Whitesides
house · D · CA · traded 2025-03-24
Sell$50K–$100K

Insider activity

SEC Form 4 transactions in INVA · 7 buys · 3 sells

InsiderSideShares
Raifeld Pavel
Chief Executive Officer · Common Stock · 2026-05-20
Tax1.13K
Basso Stephen
Chief Financial Officer · Common Stock · 2026-05-20
Tax559
Zhen Marianne
Chief Accounting Officer · Common Stock · 2026-05-20
Tax1.13K
Raifeld Pavel
Chief Executive Officer · Common Stock · 2026-05-15
Grant1.12K
Basso Stephen
Chief Financial Officer · Common Stock · 2026-05-15
Grant1.12K
Linden Josephine
Director · Non-statutory Stock Option · 2026-05-18
Grant9.17K
Linden Josephine
Director · Common Stock · 2026-05-18
Grant5.73K
Linden Josephine
Director · Common Stock · 2026-05-18
Grant9.46K
Small Derek A
Director · Common Stock · 2026-05-04
Grant9.79K
Haimovitz Jules
Director · Non-statutory Stock Option · 2026-05-04
Grant10K

SEC filings

EDGAR filings in INVA

EDGAR →

No recent SEC filings on file for INVA.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.